We serve Chemical Name:1,1,1,2,4,4,4-heptafluorobutane CAS:86884-16-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,1,1,2,4,4,4-heptafluorobutane
CAS.NO:86884-16-4
Synonyms:pc3171
Molecular Formula:C4H3F7
Molecular Weight:184.05500
HS Code:2903399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:27.5ºC
Density:1.382g/cm3
Index of Refraction:1.257
PSA:
Exact Mass:184.01200
LogP:2.83920
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like pc3171 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,pc3171 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pc3171 Use and application,pc3171 technical grade,usp/ep/jp grade.
Related News: The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. rel-(5R,7S)-7-(((tert-butyldimethylsilyl)oxy)methyl)-5,6,7,8,9,10-hexahydrobenzo[8]annulen-5-ol manufacturers And finally, CHMP also concluded its investigation into bluebird bio’s Zynteglo, finding no evidence that it causes a blood cancer known as acute myeloid leukemia. 2-[1-(1-Methyl-2-oxo-2,3-dihydro-1H-indol-3-yl)-2-oxo-2-phenyl-ethyl]-malononitrile suppliers Wavelength’s growth in the API space comes as nations around the world look to develop redundant supply chains for key generic medicines amid the pandemic. 1H-Pyrrole-1,2-diamine, 3-ethyl-N,N,N’,N’-tetramethyl- vendor & factory Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor.,Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor.
